References:
- Vadas P, Perelman B, Liss G. Platelet-activating factor, histamine,
and tryptase levels in human anaphylaxis. J Allergy Clin Immunol
2013;131(1):144-149.
- Laroche D, Dubois F, Gérard JL et al. Radioimmunoassay for plasma
histamine: a study of false positive and false negative values. Br J
Anaesth 1995;74(4):430-437.
- Ring J, Messmer K. Incidence and severity of anaphylactoid reactions
to colloid volume substitutes. Lancet 1977;309(8009):466-469.
- Valent P, Akin C, Arock M et al. Definitions, criteria and global
classification of mast cell disorders with special reference to mast
cell activation syndromes: a consensus proposal. Int Arch Allergy
Immunol 2012;157:215–225.
- Sarrat A, Couderc R, Alyanakian MA et al. Performance criteria for the
verification of IgE and tryptase assay methods: recommendations from
the AllergoBioNet network. Ann Biol Clin 2020;78(3):329-342.
(French )
- Poli C, Laurichesse M, Rostan O et al. Comparison of two enzymatic
immunoassays, high resolution mass spectrometry method and
radioimmunoassay for the quantification of human plasma histamine. J
Pharm Biomed Anal 2016;118:307-314.
- Laroche D, Debaene B. How to relate the observed event to anaphylaxis?
Practice of diagnostic investigations. Ann Fr Anesth Reanim
2011;30(3):280-293. (French )
- Thermo Fisher diagnostics. ImmunoCAP TM Tryptase -
Phadia. Fluoroenzymeimmunoassay. Directions for Use 52-5467-EN/03.
- Laroche D, Mayo P, Lefrancois C et al. Exploration in vitro de
l’anaphylaxie médicamenteuse. Immunoanal Biol Spec.1998;13(2):63-73.